H.H. Holcomb

1.4k total citations
26 papers, 1.2k citations indexed

About

H.H. Holcomb is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, H.H. Holcomb has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cognitive Neuroscience, 10 papers in Psychiatry and Mental health and 5 papers in Molecular Biology. Recurrent topics in H.H. Holcomb's work include Schizophrenia research and treatment (8 papers), Functional Brain Connectivity Studies (7 papers) and Neuroscience and Neuropharmacology Research (3 papers). H.H. Holcomb is often cited by papers focused on Schizophrenia research and treatment (8 papers), Functional Brain Connectivity Studies (7 papers) and Neuroscience and Neuropharmacology Research (3 papers). H.H. Holcomb collaborates with scholars based in United States, Czechia and Germany. H.H. Holcomb's co-authors include Carol A. Tamminga, Monte S. Buchsbaum, James M. Gold, Donald S. Shepard, Deborah R. Medoff, Gunvant K. Thaker, Nicola G. Cascella, Robert F. Dannals, Lynn E. DeLisi and Joseph C. Wu and has published in prestigious journals such as NeuroImage, American Journal of Psychiatry and Annals of the New York Academy of Sciences.

In The Last Decade

H.H. Holcomb

26 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
H.H. Holcomb 572 427 329 208 175 26 1.2k
Irina Vitcu 322 0.6× 241 0.6× 358 1.1× 138 0.7× 210 1.2× 15 922
Annabella Di Giorgio 796 1.4× 513 1.2× 381 1.2× 266 1.3× 429 2.5× 49 1.9k
K.Ranga Rama Krishnan 530 0.9× 293 0.7× 156 0.5× 250 1.2× 60 0.3× 12 1.0k
Dieter Krell 541 0.9× 361 0.8× 634 1.9× 203 1.0× 297 1.7× 44 1.7k
S. L. Dewey 447 0.8× 301 0.7× 526 1.6× 165 0.8× 207 1.2× 15 1.1k
Nina Urban 347 0.6× 235 0.6× 523 1.6× 103 0.5× 253 1.4× 20 1.1k
E. Hazlett 707 1.2× 442 1.0× 165 0.5× 298 1.4× 71 0.4× 20 1.2k
Markus Savli 447 0.8× 168 0.4× 380 1.2× 177 0.9× 151 0.9× 44 1.2k
KF Berman 423 0.7× 408 1.0× 306 0.9× 112 0.5× 114 0.7× 11 794
Patrizia Riccardi 431 0.8× 264 0.6× 459 1.4× 98 0.5× 236 1.3× 22 1.1k

Countries citing papers authored by H.H. Holcomb

Since Specialization
Citations

This map shows the geographic impact of H.H. Holcomb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.H. Holcomb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.H. Holcomb more than expected).

Fields of papers citing papers by H.H. Holcomb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.H. Holcomb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.H. Holcomb. The network helps show where H.H. Holcomb may publish in the future.

Co-authorship network of co-authors of H.H. Holcomb

This figure shows the co-authorship network connecting the top 25 collaborators of H.H. Holcomb. A scholar is included among the top collaborators of H.H. Holcomb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.H. Holcomb. H.H. Holcomb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kochunov, Peter, David C. Glahn, L. Elliot Hong, et al.. (2012). P-selectin Expression Tracks Cerebral Atrophy in Mexican-Americans. Frontiers in Genetics. 3. 65–65. 11 indexed citations
2.
Rowland, Laura M., et al.. (2010). Neural Changes Associated With Relational Learning in Schizophrenia. Schizophrenia Bulletin. 36(3). 496–503. 19 indexed citations
3.
Shepard, Donald S., H.H. Holcomb, & James M. Gold. (2005). Schizophrenia in Translation: The Presence of Absence: Habenular Regulation of Dopamine Neurons and the Encoding of Negative Outcomes. Schizophrenia Bulletin. 32(3). 417–421. 114 indexed citations
5.
Tamminga, Carol A. & H.H. Holcomb. (2004). Phenotype of schizophrenia: a review and formulation. Molecular Psychiatry. 10(1). 27–39. 191 indexed citations
6.
Beason‐Held, Lori L., H.H. Holcomb, & C.A. Tamminga. (2003). The effects of ketamine and nicotine on brain function during cognition. Schizophrenia Research. 60(1). 212–213. 1 indexed citations
7.
Weiler, Martin A., et al.. (2003). Time course of RCBF changes with haloperidol and olanzapine over a six week treatment period. Schizophrenia Research. 60(1). 226–226. 2 indexed citations
8.
Medoff, Deborah R., et al.. (2003). Abnormal limbic system connectivity in schizophrenia. Schizophrenia Research. 60(1). 228–229. 1 indexed citations
9.
Medoff, Deborah R. & H.H. Holcomb. (2000). Neural Networks: Neural Systems II. American Journal of Psychiatry. 157(8). 1212–1212. 2 indexed citations
10.
Weiler, Martin A., et al.. (2000). Blockade of ketamine-induced psychosis: A human model for a new spectrum of antipsychotic activity?. Schizophrenia Research. 41(1). 236–236. 1 indexed citations
11.
Holcomb, H.H., et al.. (2000). Cognition. American Journal of Psychiatry. 157(2). 162–162. 7 indexed citations
12.
Lahti, Adrienne C., H.H. Holcomb, Martin A. Weiler, Deborah R. Medoff, & C.A. Tamminga. (1998). Time course of rcbf changes after acute haloperidol in patients with schizophrenia. Schizophrenia Research. 29(1-2). 173–173. 4 indexed citations
13.
Holcomb, H.H., Nicola G. Cascella, Gunvant K. Thaker, et al.. (1996). Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. American Journal of Psychiatry. 153(1). 41–49. 191 indexed citations
14.
Tamminga, Carol A., H.H. Holcomb, Xuemin Gao, & Adrienne C. Lahti. (1995). Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. International Clinical Psychopharmacology. 10(Supplement 3). 29–37. 62 indexed citations
15.
Tamminga, Carol A., et al.. (1995). Glutamate pharmacology and the treatment of schizophrenia. International Clinical Psychopharmacology. 10. 29–38. 4 indexed citations
16.
Holcomb, H.H., Dana Boatman, & Carol A. Tamminga. (1995). Images in neuroscience. Cortex, VI. Auditory cortical function. American Journal of Psychiatry. 152(4). 504–504. 2 indexed citations
17.
Tamminga, C.A., et al.. (1990). Cerebral metabolic changes as a consequence of DA receptor blockade. Schizophrenia Research. 3(1). 25–25. 1 indexed citations
18.
Cohen, Rachel, et al.. (1988). Functional localization of sustained attention: Comparison to sensory stimulation in the absence of instruction. 1(1). 3–20. 148 indexed citations
19.
DeLisi, Lynn E., Monte S. Buchsbaum, H.H. Holcomb, et al.. (1985). Clinical correlates of decreased anteroposterior metabolic gradients in positron emission tomography (PET) of schizophrenic patients. American Journal of Psychiatry. 142(1). 78–81. 59 indexed citations
20.
Buchsbaum, Monte S., et al.. (1982). ROLE OF OPIOID PEPTIDES IN DISORDERS OF ATTENTION IN PSYCHPATHOLOGY. Annals of the New York Academy of Sciences. 398(1). 352–365. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026